How many insider declarations has Williams Sarah Joanne filed?

Williams Sarah Joanne has filed 3 public insider declarations with SEC (Form 4).

What is Williams Sarah Joanne's role?

Williams Sarah Joanne's reported role is not specified by the regulator across the filings.

Which companies does Williams Sarah Joanne report trades for?

Williams Sarah Joanne reports trades for AN2 Therapeutics, Inc..

What is Williams Sarah Joanne's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 1k€.

← Executives ★ Sign in to follow

WS

Williams Sarah Joanne

OFFICER

·SEC (Form 4)

AN2 Therapeutics, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€1,307

▼ Sales (2 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

2

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Explore the complete record of transactions filed by Williams Sarah Joanne. Director active across 1 company, notably AN2 Therapeutics, Inc.. Cumulatively, 3 disclosures have been logged. Split: 0 buy · 2 sells. Total volume traded: €1k. History available since 20 February 2026. The latest transaction was disclosed on 29 May 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.

Companies and markets linked to Williams Sarah Joanne

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

AN2 Therapeutics, Inc. (US)

Declarations3 total

▼

Williams Sarah Joanne

Principal Accounting OfficerExecutives29 May 2026AN2 Therapeutics, Inc.

$1,17430SEC ↗

265 shares@ US$4.430.0006% mcap100.0% of flowCommon StockSEC:0001193125-26-253622:0

▼

Williams Sarah Joanne

Principal Accounting OfficerExecutives3 Mar 2026AN2 Therapeutics, Inc.

$34721SEC ↗

327 shares@ US$1.0622.7% of flowCommon StockSEC:0001193125-26-094490:0

◆

Williams Sarah Joanne

Principal Accounting OfficerExecutives20 Feb 2026AN2 Therapeutics, Inc.

0SEC ↗

48,375 shares0Common StockSEC:0001193125-26-064166:0

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

WS

Williams Sarah Joanne

OFFICER

·SEC (Form 4)

AN2 Therapeutics, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€1,307

▼ Sales (2 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

2

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Explore the complete record of transactions filed by Williams Sarah Joanne. Director active across 1 company, notably AN2 Therapeutics, Inc.. Cumulatively, 3 disclosures have been logged. Split: 0 buy · 2 sells. Total volume traded: €1k. History available since 20 February 2026. The latest transaction was disclosed on 29 May 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.